
What to know about CTE after NYC shooting suspect appears to target NFL headquarters
CTE, or chronic traumatic encephalopathy, is a brain condition caused by repeated injuries to the head, typically over many years.
The shooter was targeting the headquarters of the National Football League, which is in the Park Avenue building where the shooting took place, authorities said.
While CTE can't be formally diagnosed without an autopsy, one third of former NFL players suspect they have the disease, according to a 2024 report. The NFL first acknowledged the link between CTE and football in 2016.
Former NFL player Phillip Adams was found to have severe CTE after he gunned down six people before taking his own life in South Carolina in 2021.
NBC News spoke with Dr. Aaron Lord, chief of neurology at NYU Langone who specializes in brain injuries, about how CTE changes the brain and a person's behavior.
What is chronic traumatic encephalopathy?
First characterized in boxers, the condition used to be called 'punch drunk syndrome' and can cause neurological conditions including early dementia, memory impairment, personality changes, and movement disorders similar to Parkinson's disease, Lord said.
CTE can affect anyone who sustains repeated head injuries.
'It's just about repetitive shock waves to the brain,' he said.
The condition's link to suicide and suicidal ideation is an area of active study, in part because there seems to be a higher rate of CTE than expected among high-caliber athletes who have committed suicide, Lord said.
Still, experts haven't drawn any conclusions about 'the incidence and prevalence of this disease in the population, or in specific athletes,' he said.
'It's a new one we're still defining,' he said.
How is CTE diagnosed?
Without an autopsy, doctors can't diagnose CTE, and even then it can be difficult to pinpoint because there's no specific criteria to diagnose it, Lord said. An autopsy must reveal evidence of tissue degeneration and abnormal clumps of certain proteins around blood vessels in the brain.
Some patients and their doctors may speculate that they have the disease because of noticeable changes in their moods and behavior. Patients also know if they've suffered blows to the head, how many and how severe.
Lord said that a brain MRI on concerned patients might reveal some changes consistent with the disease, but it's not enough for a diagnosis.
There is some overlap in symptoms with psychiatric disorders including major depressive disorder, schizophrenia and bipolar disorder, Lord said.
Lord has also seen a link between patients with CTE and homicidal ideation and impulsivity as well as other personality changes.
Lord tends to see the disease in older individuals, possibly because of earlier repeated impacts, but even one hit to the head can cause damage, even if that trauma doesn't result in CTE.
'Even somebody who's just been in a single car accident and has injured the frontal lobes of their brain can have permanent personality changes and impulse control and psychiatric changes,' he said.
Is there treatment for CTE?
Although there is no direct treatment for the disease, psychiatric medication can help with behavioral control and other symptoms, Lord said.
Not everyone who gets a concussion develops CTE, according to the Mayo clinic. Prevention is the best medicine: Avoiding head injury by using seatbelts or helmets can lower the risk of getting a CTE and other brain-injuries, Lord said.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


UPI
19 hours ago
- UPI
Clinical trial shows promise for new pancreatic cancer vaccine
A small clinical trial suggests a new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back. File Photo by Debbie Hill/UPI | License Photo A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small clinical trial suggests. Pancreatic cancer is one of the most lethal cancers, with a five-year survival rate of about 13%, according to the American Cancer Society. Further, up to 80% of cases return after treatment, the National Institutes of Health says. "If you were to ask me what disease most needs something to prevent recurrences, I'd say this one," Dr. Zev Wainberg, a leader of the trial, told NBC News. He's co-director of the University of California, Los Angeles gastrointestinal oncology program. The experimental vaccine targets KRAS gene mutations, which are found in about 25% of all cancers, the University of Texas MD Anderson Cancer Center says. This includes up to 90% of pancreatic cancers and roughly 40% of colon cancers. While these mutations have long been considered impossible to treat with drugs, researchers are finding new ways to target them. The vaccine, called ELI-002 2P, uses small chains of amino acids called peptides to train the immune system to spot and destroy cells with KRAS mutations. Unlike many cancer vaccines that are custom-made for each patient, this one is designed to be off the shelf, meaning it doesn't require the tumor to be sequenced before it's used, NBC News reported. The Phase 1 study -- reported Tuesday in Nature Medicine -- included 20 people with pancreatic cancer and five with colon cancer. All had KRAS mutations and had already undergone surgery and chemotherapy. Blood tests after surgery showed microscopic evidence of residual disease - cancer cells too small to see on scans. These leftover cells can cause the cancer to spread and return. Post-surgery, participants received up to six priming doses of the vaccine, with 13 also getting booster shots. In all, the process took six months. Here's what the results showed: 85% (21 of 25 participants) had an immune response to the KRAS mutations. About two-thirds of those had a strong enough response to help clear lingering cancer cells. Nearly 70% developed immunity to other tumor targets not included in the vaccine. A few "super-responders" had exceptionally strong immune reactions and the best outcomes. In the pancreatic cancer group, patients survived for an average of 29 months, staying recurrence-free for more than 15 months after vaccination. "That far exceeds the rates with resectable [surgically removable] cancers," Wainberg said. Cancer vaccines have been difficult to create because cancer cells share many proteins with healthy cells, making safe targets hard to find. Advances in mRNA technology and faster gene sequencing are now making more effective cancer vaccines possible. The peptides in this vaccine also have a unique "tail" that helps them stay in lymph nodes, where immune cells are activated -- a feature past peptide vaccines didn't have, said Stephanie Dougan, an associate professor at Dana-Farber Cancer Institute in Boston, who was not involved in the study. More research is needed to confirm the findings, and a Phase 2 trial is now underway to compare the vaccine with standard care. "The fact that the long-term survival really correlated with T-cell response suggests that the vaccine caused this," Dougan said, referring to the specific immune cells activated by the vaccine. "The idea that you can target KRAS is really exciting." More information The Mayo Clinic has more on pancreatic cancer. Copyright © 2025 HealthDay. All rights reserved.


USA Today
2 days ago
- USA Today
Matthew Stafford overthinking about injured back like typical 30-something
Matthew Stafford walked into this Ammortal chamber. Ammortal advertises itself as a "wellness device that aims to optimize human performance and promote holistic health through a combination of non-invasive technologies." He is not practicing today. Matthew Stafford, who is 37, has a bad back. For those of you in your 30s or who have experienced being in your 30s, this probably isn't particularly surprising news. This is the stage of life when your body tends to gradually disintegrate into a shell of its past vigorous self, and usually with little to no explanation at all. Often, the first thing to go here is the general constitution of your back, which, after roughly three decades of thanklessly carrying around your body weight and all your stressors and anxieties, decides it can't take the pressure anymore. This point in our lives is when we start seeing a ceaseless rotation of doctors and chiropractors in search of any relief from our back pain. This is when even sitting awkwardly for 20 minutes in our chair can ruin our entire week. Worse yet, this is when we wonder whether the annoying agony will ever end. MORE NFL SUMMER: 14 of the most depressing training camp battles in 2025. Fortunately for Stafford, he's not like the rest of us Average Joes and Jills. He not only has access to generational wealth as a means to treat his pain and hopefully (eventually) get back on the field on a regular basis for the Los Angeles Rams, but he also has access to all of the Rams' tremendous medical resources. He essentially has the best medical treatment money can buy. In this specific regard, he is very lucky, and I am personally rather quite jealous of him. That sound you hear right now is my back creaking like a rusty bike because I shifted three inches in my seat. Despite this, Stafford can't quite shake the all-too-typical 30-something urge to try everything unconventional and wacky BUT good old-fashioned rest. Take this report that the veteran quarterback, who has seldom practiced during this training camp, is using the "Ammortal Chamber" in an attempt to heal. Yes, dearest reader: WHAT is he using? I'm glad you asked! I'm sorry, but that description of what sounds like a glorified jetstream with red light therapy on your back is so amusing to me. Here it is again: "[A] wellness device that aims to optimize human performance and promote holistic health through a combination of non-invasive technologies." I don't know about you, but that sounds like some desperate pseudoscience hullabaloo to me. Red light therapy isn't about to shift the general sanctity of the lower back for the better. It might help with your acne and crow's feet, but it's not gonna meaningfully fix your back problems to be healthy enough for evading hyper-athletic 250-plus-pound pass-rushers multiple times every Sunday. Once that back thing goes, it tends to stay gone, folks. If this has already happened to you, you should make your peace with your new reality. This, again, is where Stafford is most relatable to us. He probably could focus on other, more well-founded means of treatment. It'd probably be a better use of his time and money, too. Instead, he's slowly going to drive himself crazy, trying all sorts of options that ultimately amount to nothing before he inevitably finds himself back at a frustrating square one. Been there, pal. My condolences.
Yahoo
2 days ago
- Yahoo
Matthew Stafford doesn't practice with Rams as originally expected
Matthew Stafford did not practice on Monday despite being expected to return to the field as he deals with an aggravated disc in his back. [Join or create a Yahoo Fantasy Football league for the 2025 NFL season] The Los Angeles Rams quarterback "didn't feel good enough," according to head coach Sean McVay and the team did not want to rush him while he recovers. Stafford, 37, was expected to take part in individual drills on Monday, two days after he threw 68 passes as the team's practice facility. There is the chance Stafford practices on Tuesday, but McVay said they will see how his back feels in the morning. As for the possibility of surgery, that discussion has not been had with the medical staff. 'There's been a lot of conversations about what's the best method of how we want to approach it," McVay said, per ESPN's Sarah Barshop. "That hasn't been something that comes up.' According to Adam Grosbard of the LA Daily News, instead of practicing Stafford walked into an Ammortal Chamber, which the company describes as a "wellness device that aims to optimize human performance and promote holistic health through a combination of non-invasive technologies." McVay said that Stafford used the device for red-light therapy, something that has been offered to the entire Rams team, not just Stafford. McVay confirmed last week that Stafford was dealing with a back issue, but that it was expected the veteran quarterback would be ready for Week 1. He added that Stafford had visited a back specialist for a second time and also received an epidural to aid in his recovery.